Advanced search
Log in
Press Room
Releases
Multimedia
About
AkzoNobel acquires majority ownership of Japanese joint venture
12/17/2008 2:31 AM EST
AkzoNobel has agreed to acquire a 75/25 majority interest in its Kayaku Akzo Co. Ltd (KAC) joint venture with Nippon Kayaku.
KAC has been a 50/50 joint venture between the two companies for nearly 40 years. A leading supplier of organic peroxides to Japan, the business has sales offices in Tokyo and Osaka, Japan, as well as a manufacturing and research and development facility in Asa.
“This opportunity allows AkzoNobel to gain access to the Japanese market and take on the leadership in the longstanding cooperation,” said Rob Frohn, Board member responsible for AkzoNobel Specialty Chemicals.
Added AkzoNobel Polymer Chemicals General Manager Alan Kwek: “We respect the success KAC and its employees have had to date and we look forward to our continued partnership with Nippon Kayaku.”
The general management of the new organization will effectively remain unchanged and will be governed by an oversight committee of a Board of Directors representing both AkzoNobel and Nippon...
AkzoNobel completes REACH pre-registration
12/5/2008 7:00 AM EST
AkzoNobel has submitted its list of substances in compliance with the European Union’s REACH legislation.
The company completed the process ahead of the December 1 cut-off...
AkzoNobel opens Elotex production facility in China
11/11/2008 4:41 AM EST
AkzoNobel Functional Chemicals has officially opened a new production site in Shanghai, China, for its Elotex building material additives business.
Akzo Nobel divests PVC additives business
3/15/2007 3:02 AM EST
Arnhem, the Netherlands, March 15, 2007 — Akzo Nobel has divested its Akcros Chemicals PVC additives business to UK-based private investment firm GIL Investments. Financial...
Historic joint launch for Akzo Nobel’s flagship reports
3/14/2007 4:00 AM EST
Arnhem, the Netherlands, March 14, 2007 — Akzo Nobel has today published its Annual and Corporate Social Responsibility Reports for 2006—the first time that the company has...
Akzo Nobel Announces Intended Sale of Organon BioSciences to Schering-Plough for EUR 11 billion
3/12/2007 3:53 AM EST
Arnhem, the Netherlands, March 12, 2007 – Akzo Nobel is pleased to announce that on March 11, 2007, it received an offer for the purchase of its wholly owned subsidiary Organon...
Akzo Nobel approves separation and Board changes
3/1/2007 3:27 AM EST
Arnhem, the Netherlands, March 1, 2007 — Following on from the recent announcement regarding the impending separation of the company, Akzo Nobel’s Board of Management and...
Akzo Nobel confirms IPO timing of Organon BioSciences
2/26/2007 4:00 AM EST
Arnhem, the Netherlands, Monday, February 26 - Akzo Nobel today confirms the start of the process to list Organon BioSciences N.V. (OBS) on Euronext Amsterdam. Investor...
Akzo Nobel reconfirms listing of Organon BioSciences
1/25/2007 3:21 AM EST
Arnhem, the Netherlands, January 25, 2007 — Akzo Nobel has previously announced its intention to separate its Pharma business, preferably through a listing of approximately 20 to...
Akzo Nobel agrees to sell 50 percent stake in Flexsys
12/15/2006 10:33 AM EST
Arnhem, the Netherlands, December 15, 2006 — Akzo Nobel has reached an agreement in principle to sell its 50 percent stake in rubber chemicals business Flexsys to joint venture...
Akzo Nobel rejects damages claim
12/1/2006 4:00 AM EST
Arnhem, the Netherlands, December 1, 2006 — In its decision of December 10, 2003, the European Commission established that several companies, including Akzo Nobel, violated the EU...
Organon continues with the development of asenapine
11/28/2006 2:51 AM EST
Arnhem, The Netherlands, November 28, 2006 — Organon has decided to continue with the development of asenapine. This follows on from the decision taken by Organon and Pfizer to...
Joint press release - Organon and Pfizer discontinue their collaboration on asenapine
11/28/2006 2:50 AM EST
New York, New York, USA, November 28, 2006 and Arnhem, The Netherlands, November 28, 2006 — Organon and Pfizer today announced that they have agreed to discontinue their...
Akzo Nobel appoints Dr. Jörg Spiekerkötter as CFO of Organon BioSciences N.V.
10/26/2006 2:10 AM EST
Arnhem, the Netherlands, October 26, 2006 — Akzo Nobel has appointed Dr. Jörg Spiekerkötter as Chief Financial Officer of its subsidiary Organon BioSciences N.V. He will...
Akzo Nobel CEO outlines new strategy and targets at company’s Fit For the Future conference
10/19/2006 2:33 AM EST
Arnhem, the Netherlands, October 19, 2006 — Akzo Nobel has announced strategic plans designed to accelerate profitable growth and drive the company’s ongoing commitment to...
Akzo Nobel secures license for breakthrough aerospace primer technology
10/16/2006 2:15 AM EST
Arnhem, the Netherlands, October 16, 2006 - Akzo Nobel’s Aerospace Coatings business (ANAC) has announced that it is the first to develop products to contain breakthrough...
Intervet supports ECVIM-CA and ESVE
10/6/2006 4:00 AM EST
Boxmeer, October 6, 2006 – Intervet presented two awards during ECVIM-CA annual congress and ESVE meeting, as part of...
New chemicals plants represent landmark for Akzo Nobel
9/26/2006 3:37 AM EST
Arnhem, the Netherlands, September 26, 2006 – When Akzo Nobel officially opens its two new chemicals plants in Delfzijl today it will mark the completion of the company’s biggest...
Intervet’s equine West Nile vaccine approved by USDA
9/14/2006 4:04 AM EST
Arnhem, the Netherlands, September 14, 2006 — An equine vaccine developed by Akzo Nobel’s animal health business Intervet, which is indicated for use in horses at risk from West...
Akzo Nobel shareholders approve separation proposal
9/7/2006 9:51 AM EST
Arnhem, the Netherlands, September 7, 2006 — Akzo Nobel has moved a step closer to separating into two independent companies after shareholders approved the company’s proposal at...
Nobilon, BioDiem and leading U.S. scientists developing pandemic avian flu vaccine
8/30/2006 4:30 AM EST
Arnhem, the Netherlands, August 30, 2006 — Scientists at Akzo Nobel’s Nobilon International human vaccines business working to fight the threat of a global bird flu pandemic have...
SEE ALL NEWS
AkzoNobel
RSS
Subscribe by Email
View more
Tweet
Media
Picture 1 PR Intervet
10/6/2006 4:00 AM EST -
AkzoNobel
Picture 2 PR Intervet
10/6/2006 4:00 AM EST -
AkzoNobel
MPP-systems
3/2/2005 3:40 AM EST -
AkzoNobel
more